choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Darapladib

Darapladib Newsletter
  • Ups & Downs: Top Pharmaceutical Stocks Post-COVID 20 Aug 2022 13:53 GMT

    GlaxoSmithKline, GSK didn’t come out with the first COVID medicationdrug will succeed even after making it through late-stage trials. The FDAvaccine turned down, an immune therapy lung cancer treatment … many large pharmaceutical and biotech companies have …

  • Why COVID-19 Treatment Options Remain So Elusive 03 Oct 2021 18:52 GMT

    … The new antiviral pill, developed by pharmaceutical giant Merck … have vaccines and we don’t have drugs According … first – darapladib – was originally developed by GlaxoSmithKline to treat … COVID treatment. In fact, Phase III clinical trials are …

  • Israeli scientists identify 3 existing drugs that can eliminate COVID-19 29 Jul 2021 16:01 GMT

    … Rather than create a Covid vaccine from scratch, Professor Shai … three prospective drugs with Times of Israel. One is darapladib, which … reviewed in the medical journals, Viruses and Pharmaceuticals. But Arkin’s … have a variety of treatments — a large arsenal.”

  • three drugs that are “almost 100%” effective 21 Jul 2021 16:51 GMT

    … of search for the ideal medicine was tantamount to “finding … Israel: We already have the vaccine, but we cannot rest … 3,000 drugs examined stand out. These are darapladib (currently used … work with a pharmaceutical company so that the drugs he identified in …

  • Israeli lab: Some existing drugs could stop COVID at almost 100% 20 Jul 2021 15:59 GMT

    … of them are Darapladib, used for the treatment of atherosclerosis, … The Pfizer and Moderna vaccines target the spike protein.   … for a pharmaceutical partner to help carry these trials through.   … Food and Drug administration approval for the drug Remdesivir …

  • The best report on why it’s unsafe for the FDA to skip phase 3 trials comes from the FDA 02 Sep 2020 20:45 GMT

    … a Phase 1 trial are focused on … treatment was ineffective, it was also unsafe. This included trials of a vaccinedrug interactions, effects that were amplified by the presence of other medical … , darapladib, torcetrapib) to Staph infection (V710 vaccine), and …

  • GlaxoSmithKline: Why This Diversified Stock Is A Definite Buy In 2018 01 Feb 2018 03:37 GMT

    GlaxoSmithKline (GSK) is one pharmaceutical company, very … overall treatment adherence for HIV patients. GlaxoSmithKline is one … the Shingrix vaccine, approved by the FDA in October … for its cardiovascular drug candidates, darapladib and Iosmapimod, Duchenne …

  • Glaxo Names Roche Veteran as Research Head 08 Nov 2017 18:54 GMT

    … but stable vaccine and consumer-healthcare … head of Glaxo';s pharmaceuticals division. She also … a string of biotech drugs, including blockbuster cancer treatment Herceptin. During … disappointments, including Darapladib, a heart drug it hoped would …

  • Diabetic Macular Edema Pipeline Therapeutics Companies and Drugs Profile Insights 2017 Available at RnR Market Research 24 Jul 2017 11:38 GMT

    Pharmaceuticals Inc , Araim Pharmaceuticals Inc , Boehringer Ingelheim GmbH , Cell Medica Ltd , Chengdu Kanghong Pharmaceuticals … , danazol, darapladib, dexamethasone acetate, dexamethasone acetate, dexamethasone dipropionate XR, difluprednate, Drug for …

  • UPDATE 2-Novartis heart drug success opens up new care option 22 Jun 2017 11:59 GMT

    … pivotal trial, potentially changing ideas about treatment. … its experimental darapladib failed in 2013. … statins or blood-thinners, it could be given on top of standard medicinestrial findings, amid resistance over the price of the drug and doctors …

Satisfied with the content?

Continue to create your account.